MetaCap

Indaptus Therapeutics (INDP) News

NASDAQ: INDPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.82-0.31 (-9.90%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

INDP news summary

We found 1 recent headline mentioning Indaptus Therapeutics (INDP): 0 in the past week and 1 in the past 30 days, most often from GlobeNewswire. INDP is making an outsized move today, down 9.90% at $2.82, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update", was published by GlobeNewswire on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Indaptus Therapeutics headlines

Compare INDP